Zhong WD - Search Results

1

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.

Fu X, Chen G, Cai ZD, Wang C, Liu ZZ, Lin ZY, Wu YD, Liang YX, Han ZD, Liu JC, Zhong WD. Fu X, et al. Among authors: zhong wd. Onco Targets Ther. 2016 Apr 15;9:2211-20. doi: 10.2147/OTT.S101994. eCollection 2016. Onco Targets Ther. 2016. PMID: 27143916 Free PMC article.

2

[Early diagnosis of bladder cancer by special fluorescence spectrum: an in vitro experiment].

Zou J, He HC, Yao YB, Dai QS, Han ZD, Zhong WD. Zou J, et al. Among authors: zhong wd. Zhonghua Yi Xue Za Zhi. 2007 Sep 25;87(36):2544-6. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18067829 Chinese.

3

Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q. Zhong W, et al. Clin Invest Med. 2008;31(1):E8-E15. doi: 10.25011/cim.v31i1.3136. Clin Invest Med. 2008. PMID: 18312749

4

Protective effect of ganoderan on renal damage in rats with chronic glomerulonephritis.

Zhong WD, He HC, Ou RB, Bi XC, Dai QS, Han ZD, Liang YX, Ye YK, Qin WJ, Li Z, Zeng GH, Zhu G. Zhong WD, et al. Clin Invest Med. 2008;31(4):E212-7. doi: 10.25011/cim.v31i4.4782. Clin Invest Med. 2008. PMID: 18682045

5

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN. Zhong WD, et al. Oncology. 2008;75(3-4):230-6. doi: 10.1159/000163852. Epub 2008 Oct 14. Oncology. 2008. PMID: 18852494

6

Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.

He HC, Bi XC, Zheng ZW, Dai QS, Han ZD, Liang YX, Ye YK, Zeng GH, Zhu G, Zhong WD. He HC, et al. Among authors: zhong wd. Med Oncol. 2009;26(3):303-8. doi: 10.1007/s12032-008-9120-9. Epub 2008 Nov 12. Med Oncol. 2009. PMID: 19003546

7

CD147 expression indicates unfavourable prognosis in prostate cancer.

Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Chen ZN, Zhong WD. Han ZD, et al. Among authors: zhong wd. Pathol Oncol Res. 2009 Sep;15(3):369-74. doi: 10.1007/s12253-008-9131-z. Pathol Oncol Res. 2009. PMID: 19048397 Free article.

8

Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.

Bi X, He H, Ye Y, Dai Q, Han Z, Liang Y, Zhong W. Bi X, et al. Med Oncol. 2010 Mar;27(1):145-51. doi: 10.1007/s12032-009-9185-0. Epub 2009 Feb 26. Med Oncol. 2010. PMID: 19242826

9

Expression and clinical significance of CD147 in genitourinary carcinomas.

Han ZD, He HC, Bi XC, Qin WJ, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Zhu G, Chen ZN, Zhong WD. Han ZD, et al. Among authors: zhong wd. J Surg Res. 2010 May 15;160(2):260-7. doi: 10.1016/j.jss.2008.11.838. Epub 2008 Dec 10. J Surg Res. 2010. PMID: 19286191

10

Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.

Bi X, Zhu G, Han Z, Ye Y, Liang Y, Zhang L, Hao Z, Zeng G, He H, Zhong W. Bi X, et al. Clin Invest Med. 2009 Jun 1;32(3):E229-38. Clin Invest Med. 2009. PMID: 19480741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters